Adicet Bio Insider Trades
NASDAQ: ACETHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 3 · $1.60M
- Sales
- 4 · $674.85K
- Shares bought / sold
- 223.60K / 104.66K
- Net activity
- Net buying $929,087
Adicet Bio insider activity
Over the last 12 months, Adicet Bio insiders reported 12 transactions on SEC Form 4: 3 open-market purchases and 4 sales. Insiders bought $1.6 million and sold $674,847 worth of stock, for net insider buying of $929,087. The largest seller was ORBIMED ADVISORS LLC & OrbiMed Capital GP V LLC & OrbiMed Capital GP VI LLC & OrbiMed Genesis GP LLC & OrbiMed Advisors Israel II Ltd & OrbiMed Israel GP II, L.P. & OrbiMed Israel GP Ltd. & OrbiMed Israel BioFund GP Limited Partnership, with $674,847 in reported sales.
The most recent filing shows RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & Kolchinsky Peter & Shah Rajeev M. (10% Owner) reporting a transaction in 250,000 shares on Apr 27, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ACET's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ACET insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Apr 27, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & Kolchinsky Peter & Shah Rajeev M.10% Owner | other | 250,000 | — | Form 4 |
| Apr 8, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP V LLC & OrbiMed Capital GP VI LLC & OrbiMed Genesis GP LLC & OrbiMed Advisors Israel II Ltd & OrbiMed Israel GP II, L.P. & OrbiMed Israel GP Ltd. & OrbiMed Israel BioFund GP Limited Partnership10% Owner | Sale | 40,416 | $263.51K | Form 4 |
| Apr 8, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP V LLC & OrbiMed Capital GP VI LLC & OrbiMed Genesis GP LLC & OrbiMed Advisors Israel II Ltd & OrbiMed Israel GP II, L.P. & OrbiMed Israel GP Ltd. & OrbiMed Israel BioFund GP Limited Partnership10% Owner | Sale | 32,523 | $204.57K | Form 4 |
| Apr 7, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP V LLC & OrbiMed Capital GP VI LLC & OrbiMed Genesis GP LLC & OrbiMed Advisors Israel II Ltd & OrbiMed Israel GP II, L.P. & OrbiMed Israel GP Ltd. & OrbiMed Israel BioFund GP Limited Partnership10% Owner | Sale | 2,400 | $15.31K | Form 4 |
| Apr 7, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP V LLC & OrbiMed Capital GP VI LLC & OrbiMed Genesis GP LLC & OrbiMed Advisors Israel II Ltd & OrbiMed Israel GP II, L.P. & OrbiMed Israel GP Ltd. & OrbiMed Israel BioFund GP Limited Partnership10% Owner | Sale | 29,319 | $191.45K | Form 4 |
| Feb 20, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & Kolchinsky Peter & Shah Rajeev M.10% Owner | Buy | 74,751 | $543.44K | Form 4 |
| Feb 19, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & Kolchinsky Peter & Shah Rajeev M.10% Owner | Buy | 74,268 | $535.47K | Form 4 |
| Feb 18, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & Kolchinsky Peter & Shah Rajeev M.10% Owner | Buy | 74,577 | $525.02K | Form 4 |
| Jan 24, 2026 | Schor ChenPresident & CEO | Tax withholding | 1,755 | $14.81K | Form 4 |
| Jan 24, 2026 | Healey DonChief Technology Officer | Tax withholding | 535 | $4.52K | Form 4 |
| Jan 24, 2026 | Harvey Brian NicholasChief Financial Officer | Tax withholding | 546 | $4.61K | Form 4 |
| Jan 24, 2026 | Aftab BlakeChief Scientific Officer | Tax withholding | 535 | $4.52K | Form 4 |
| Oct 8, 2025 | ORBIMED ADVISORS LLC & OrbiMed Capital GP V LLC & OrbiMed Capital GP VI LLC & OrbiMed Genesis GP LLC & OrbiMed Advisors Israel II Ltd & OrbiMed Israel GP II, L.P. & OrbiMed Israel GP Ltd. & OrbiMed Israel BioFund GP Limited Partnership10% Owner | Buy | 3,500,000 | $3.50M | Form 4 |
| Oct 8, 2025 | ORBIMED ADVISORS LLC & OrbiMed Capital GP V LLC & OrbiMed Capital GP VI LLC & OrbiMed Genesis GP LLC & OrbiMed Advisors Israel II Ltd & OrbiMed Israel GP II, L.P. & OrbiMed Israel GP Ltd. & OrbiMed Israel BioFund GP Limited Partnership10% Owner | Buy | 1,500,000 | $1.50M | Form 4 |
| Jun 11, 2025 | Sinclair AndrewDirector | Award | 5,900 | — | Form 4 |
| Jun 11, 2025 | Peng KatieDirector | Award | 5,900 | — | Form 4 |
| Jun 11, 2025 | DUBIN STEVEDirector | Award | 5,900 | — | Form 4 |
| Jun 11, 2025 | Chodakewitz JeffreyDirector | Award | 5,900 | — | Form 4 |
| Jun 11, 2025 | Klickstein LloydDirector | Award | 5,900 | — | Form 4 |
| Jan 24, 2025 | Aftab BlakeChief Scientific Officer | Tax withholding | 6,270 | $5.78K | Form 4 |
| Jan 24, 2025 | Schor ChenPresident & CEO | Tax withholding | 28,101 | $25.90K | Form 4 |
| Jan 24, 2025 | Harvey Brian NicholasChief Financial Officer | Tax withholding | 8,752 | $8.07K | Form 4 |
| Jan 24, 2025 | Healey DonChief Technology Officer | Tax withholding | 8,560 | $7.89K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4